FDA sunscreen rule
This article was originally published in The Rose Sheet
Executive Summary
FDA is extending the comment period for its proposed sunscreen regulation to Dec. 26, 2007; the 90-day comment period initially was set to end Nov. 26. The proposed rule will amend the 1999 FDA final rule on sunscreens that block UVB rays to incorporate new testing and labeling requirements for products that protect against UVA rays (1"The Rose Sheet" Aug. 27, 2007, p. 3). The extension is in response to nine requests submitted to extend the comment period; eight of the requests were for an additional nine months in order to conduct laboratory testing and consumer studies on the proposed labeling system. "By extending the comment period for 30 days, FDA is balancing industry concerns and the interests of public health to ensure that sunscreen products properly inform customers of the level of protection they provide against UVA and UVB rays," the agency says Nov. 27...
You may also be interested in...
Sunscreen Proposed Rule May Create UVA Protection Marketing Opportunity
FDA's proposed rule amending its final monograph on sunscreens to include UVA ray protection standards could create new marketing opportunities for manufacturers
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.